EUVIMEDObjevte EUVIMED
Open access

Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed‐Phase Precipitate Formation in Biorelevant Media

Miao Zhang iD, Shudong Zhang, Bin Wu, Zhe Zhang, Qin Hu, Lin Wang, Dongyang Liu iD

Biopharmaceutics & Drug Disposition · 2026-04 · 47 (2) · 88-99

DOI: 10.1002/bdd.70025 ↗

At a glance

Journal article in Biopharmaceutics & Drug Disposition, published online on 2026-04-07. Written by Miao Zhang and 6 co-authors. Institution: Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China. Major MEDLINE topics: Pharmaceutical Preparations. 57 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Although precipitation of poorly soluble drugs in the gastrointestinal (GI) tract is often considered detrimental to bioavailability, the solid‐state nature of the precipitate, either crystalline or amorphous, may critically redefine its impact. Contrasting with reported crystalline precipitates of weakly basic drugs, this study investigates XZP8257 (C 27 H 23 Cl 2 N 3 O 4 S), a poorly soluble weakly acidic/zwitterionic compound (BCS II), to explore how GI fluid composition governs precipitate formation and its resulting physicochemical properties. Precipitates were generated in simulated intestinal media with varied bile salt concentrations and pH values. Their solid‐state forms were characterized using XRD, SEM, FTIR, and DSC, whereas dissolution performance was evaluated via equilibrium solubility and intrinsic dissolution rate (IDR) measurements. Elevated bile salt concentrations induced a molecular structural transition in XZP8257 and facilitated the formation of crystalline–amorphous mixed precipitates, a phenomenon distinct from the crystalline precipitates typically reported. These novel precipitates exhibited a 5.29‐ to 22.1‐fold increase in equilibrium solubility and a 0.7‐ to 2.35‐fold improvement in IDR compared to the crystalline API. This study reveals that for weakly acidic compounds like XZP8257, precipitate formation in the GI tract can lead to high energy, readily redissolving solid forms, potentially enhancing rather than limiting absorption. This challenges the uniform negative view of precipitation and underscores the necessity of compound‐specific precipitate characterization to accurately predict oral absorption, especially in physiologically based biopharmaceutics models.

Subjects

MeSH terms (MEDLINE)

Pharmaceutical PreparationsBile Acids and SaltsChemical PrecipitationCrystallizationHydrogen-Ion ConcentrationSolubility

Author keywords

amorphous formcrystalline‐amorphous mixturephysicochemical propertiesprecipitatesweakly acidic drug

Substances

Bile Acids and SaltsPharmaceutical Preparations

Authors and institutions

  • Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
  • NMPA Key Laboratory for Research and Evaluation of Generic Drugs, Beijing Institute for Drug Control, Beijing, China.

ORCID profiles: Miao Zhang, Dongyang Liu

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhang, M., Zhang, S., Wu, B., Zhang, Z., Hu, Q., Wang, L., & Liu, D. (2026). Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed‐Phase Precipitate Formation in Biorelevant Media. Biopharmaceutics & Drug Disposition, 47(2), 88-99. https://doi.org/10.1002/bdd.70025

Vancouver

Zhang M, Zhang S, Wu B, Zhang Z, Hu Q, Wang L, et al. Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed‐Phase Precipitate Formation in Biorelevant Media. Biopharmaceutics & Drug Disposition. 2026;47(2):88-99. doi:10.1002/bdd.70025

BibTeX
@article{Zhang2026,
  author = {Zhang, Miao and Zhang, Shudong and Wu, Bin and Zhang, Zhe and Hu, Qin and Wang, Lin and Liu, Dongyang},
  title = {Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed‐Phase Precipitate Formation in Biorelevant Media},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2026},
  volume = {47},
  number = {2},
  pages = {88--99},
  doi = {10.1002/bdd.70025}
}
Start for free →